ELMO2
protein-codingengulfment and cell motility 2, the group of Engulfment and cell motility proteins
Gene summary
The protein encoded by this gene interacts with the dedicator of cyto-kinesis 1 protein. Similarity to a C. elegans protein suggests that this protein may function in phagocytosis of apoptotic cells and in cell migration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~66.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011744
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009954
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011744
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011744
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011744
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Musculoskeletal
Intervention: Cardiovascular
Rationale: The condition involves vascular malformation often affecting the vertebral column and the skull, with life-threatening complications after tooth extraction as well as spontaneous severe bleeding episodes, and awareness may allow preventive measures and aggressive management, which may ameliorate morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ELMO2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_133171.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 11 | 1 | 14 | ||
| missense | 62 | 1 | 63 | |||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 1 | 5 | 8 | ||
| Total | 4 | 3 | 69 | 12 | 1 | 89 |
Highest pathogenic variant AF is 0.000004338556
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_573403.1 | 20 | MANE Select | |
| Ensembl | ENSP00000290246.6 | 20 | MANE Select | |
| RefSeq | NP_001305182.1 | 16 | Standard | |
| RefSeq | NP_877496.1 | 20 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Bacterial invasion of epithelial cells - Homo sapiens (human)
- Shigellosis - Homo sapiens (human)
- Signaling by PTK6
- Signal Transduction
- VEGFA-VEGFR2 Pathway
Biological Process
- apoptotic process
- cytoskeleton organization
- Fc-gamma receptor signaling pathway involved in phagocytosis
- vascular endothelial growth factor receptor signaling pathway
- cell chemotaxis
Molecular Function
- protein binding
- SH3 domain binding
- receptor tyrosine kinase binding
Cellular Component
- cytosol
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000290246
- Coding exons
- 20
- Length
- 67017
- Individuals with no LoFs
- 125722
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 26
- Defined
- 125748
- p
- 0.000103
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.27 | 235 | 425 | 0.553 | 0.0000243 | 4791 |
| Missense (PolyPhen) | 23 | 101.66 | 0.22624 | 1176 | ||
| Synonymous | -0.446 | 162 | 155 | 1.05 | 0.00000845 | 1339 |
| Loss of Function | 3.95 | 17 | 45.8 | 0.371 | 0.00000286 | 461 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.000097 | 0.000097 | rare |
| South Asian | 0.000067 | 0.000065 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Acts in association with DOCK1 and CRK. Was initially proposed to be required in complex with DOCK1 to activate Rac Rho small GTPases. May enhance the guanine nucleotide exchange factor (GEF) activity of DOCK1. {ECO:0000269|PubMed:11595183, ECO:0000269|PubMed:11703939, ECO:0000269|PubMed:20679435, ECO:0000269|PubMed:27476657}.;
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- LoFtool
- 0.725
- RVIS EVS
- -0.82
- RVIS percentile EVS
- 11.77
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.661
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |